AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10357032 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 340
Study 9364674 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐L* vaccine (20 micrograms/dose)
Number of subjects: 100
Study 9364674 — intervention group
Group type: COMPARATOR
Intervention: Engerix‐B vaccine (20 micrograms/dose)
Number of subjects: 100
Study 1494594 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol and lorazepam combined
Number of subjects: 61
Study 1494594 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol alone
Number of subjects: 61
Study 3083705 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral neomycin and erythromycin
Number of subjects: 60
Study 3083705 — intervention group
Group type: COMPARATOR
Intervention: Intravenous metronidazole and ceftriaxone
Number of subjects: 60
Study 30956983 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 10 mg
Number of subjects: 328
Study 30956983 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 328
Study 30956983 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 328
Study 30956983 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin and Mirabegron
Number of subjects: 328
Study 29912663 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell therapy (bone marrow-derived mononuclear cells)
Number of subjects: 40
Study 29912663 — intervention group
Group type: COMPARATOR
Intervention: Compression therapy alone (control group)
Number of subjects: 40
Study 27113487 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim pressure garment (IPG) therapy (4-6 mmHg) applied post-operatively on day 5
Number of subjects: 0
Study 27113487 — intervention group
Group type: COMPARATOR
Intervention: Control group (no compression to donor sites)
Number of subjects: 0
Study 24831251 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus 10 mg zolpidem nightly
Number of subjects: 160
Study 24831251 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) alone
Number of subjects: 160
Study 21910714 — intervention group
Group type: EXPERIMENTAL
Intervention: 311-nm UVB therapy
Number of subjects: 10
Study 21910714 — intervention group
Group type: COMPARATOR
Intervention: Control (unirradiated body halves)
Number of subjects: 10
Study 20216207 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC) plus Dopamine (DA) infusion
Number of subjects: 43
Study 20216207 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC) infusion
Number of subjects: 43
Study 20216207 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 43
Study 18541389 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200mg/day)
Number of subjects: 157
Study 18541389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 18541389 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 157
Study 16082540 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted image-free navigation system (study group)
Number of subjects: 45
Study 16082540 — intervention group
Group type: COMPARATOR
Intervention: Free-hand implantation (control group)
Number of subjects: 45
Study 11837736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Number of subjects: 48
Study 11837736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha and cisapride
Number of subjects: 48
Study 11837736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta
Number of subjects: 48
Study 11837736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta and cisapride
Number of subjects: 48
Study 10037308 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 0
Study 10037308 — intervention group
Group type: COMPARATOR
Intervention: Minilaparotomy
Number of subjects: 0
Study 7722910 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% flurbiprofen
Number of subjects: 681
Study 7722910 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% indomethacin
Number of subjects: 681
Study 7722910 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 681
Study 7722910 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 681
Study 8314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 3 MU three times weekly for three months
Number of subjects: 4
Study 8314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 3 MU three times weekly for six months
Number of subjects: 4
Study 8314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 6 MU two times weekly for six months
Number of subjects: 4
Study 8314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 6 MU three times weekly for six months
Number of subjects: 4
Study 8314480 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 4
Study 3886256 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm imipenem and cilastatin every 6 hours for 10 days
Number of subjects: 12
Study 3886256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29964249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-curing resin cement (Calibra)
Number of subjects: 36
Study 29964249 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-curing flowable composite (Charisma Flow)
Number of subjects: 36
Study 29964249 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem)
Number of subjects: 36
Study 29964249 — intervention group
Group type: COMPARATOR
Intervention: Calibra and Charisma Flow
Number of subjects: 36
Study 29964249 — intervention group
Group type: COMPARATOR
Intervention: Charisma Flow and RelyX Unicem
Number of subjects: 36
Study 29964249 — intervention group
Group type: COMPARATOR
Intervention: Calibra and RelyX Unicem
Number of subjects: 36
Study 29964249 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable composite (Charisma Flow)
Number of subjects: 36
Study 27721533 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine 10 mg/kg on Day 1, 10 mg/kg on Day 2, and 5 mg/kg on Day 3
Number of subjects: 25
Study 27721533 — intervention group
Group type: COMPARATOR
Intervention: Control group (normally nourished children)
Number of subjects: 25
Study 24990776 — intervention group
Group type: EXPERIMENTAL
Intervention: Vipromak added to treatment protocol
Number of subjects: 80
Study 24990776 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment scheme
Number of subjects: 80
Study 22677218 — intervention group
Group type: EXPERIMENTAL
Intervention: milnacipran 100 mg/d
Number of subjects: 516
Study 22677218 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 516
Study 20482594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (group DP) for 12 weeks
Number of subjects: 98
Study 20482594 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea (group DS) for 12 weeks
Number of subjects: 98
Study 20482594 — intervention group
Group type: COMPARATOR
Intervention: Comparison between group DP and group DS
Number of subjects: 98
Study 17986678 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 86
Study 17986678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 27945299 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy: docetaxel 75 mg/m² and cisplatin 75 mg/m² D1 q 3 wks x 2, followed by cisplatin 40 mg/m² weekly x 6-8 concurrent with RT (66 Gy in 2-Gy fractions)
Number of subjects: 60
Study 27945299 — intervention group
Group type: COMPARATOR
Intervention: Control arm: concurrent cisplatin-RT as arm 1 without neoadjuvant chemotherapy
Number of subjects: 60
Study 11986439 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice (sorbitol 0.5 g/dL; 2.6:1 fructose-to-glucose ratio)
Number of subjects: 30
Study 11986439 — intervention group
Group type: COMPARATOR
Intervention: White grape juice (sorbitol-free; 1:1 fructose-to-glucose ratio)
Number of subjects: 30
Study 10717776 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG/EE (Levonorgestrel 100 micrograms + Ethinyl Estradiol 20 micrograms)
Number of subjects: 58
Study 10717776 — intervention group
Group type: EXPERIMENTAL
Intervention: NETA/EE (Norethindrone Acetate 1000 micrograms + Ethinyl Estradiol 20 micrograms)
Number of subjects: 58
Study 7741611 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 20
Study 7741611 — intervention group
Group type: COMPARATOR
Intervention: Concentric training
Number of subjects: 20
Study 2199890 — intervention group
Group type: EXPERIMENTAL
Intervention: Single running suture with postoperative suture adjustment
Number of subjects: 18
Study 2199890 — intervention group
Group type: COMPARATOR
Intervention: Standard double running suture procedure with no postoperative adjustment
Number of subjects: 18
Study 7267475 — intervention group
Group type: EXPERIMENTAL
Intervention: prenylamine 180 mg daily
Number of subjects: 29
Study 31837201 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management retraining program
Number of subjects: 41
Study 31837201 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 41
Study 29951803 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-free BA9-coated stent (DCS)
Number of subjects: 805
Study 29951803 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 805
Study 28129756 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing and cognitive behavioural therapy based intervention for AUDs, administered over 16 sessions at 8 HIV clinics.
Number of subjects: 0
Study 28129756 — intervention group
Group type: COMPARATOR
Intervention: World Health Organization Mental Health Gap Action Programme (WHO mhGAP) guide, adapted for the Zimbabwean context.
Number of subjects: 0
Study 25886009 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (MINSTOP app)
Number of subjects: 300
Study 25886009 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 23843062 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin treatment (Group I)
Number of subjects: 47
Study 23843062 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training (Group II)
Number of subjects: 47
Study 21279328 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin
Number of subjects: 96
Study 21279328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 20002420 — intervention group
Group type: EXPERIMENTAL
Intervention: Major trauma group
Number of subjects: 565
Study 20002420 — intervention group
Group type: COMPARATOR
Intervention: Minor or no trauma group
Number of subjects: 565
Study 20002420 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 565
Study 20002420 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with minor or no trauma
Number of subjects: 565
Study 20002420 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with major trauma
Number of subjects: 565
Study 17970680 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing (SRP)
Number of subjects: 37
Study 17970680 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-Mouth Scaling (FMS)
Number of subjects: 37
Study 15555005 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleet Prep Kit 3 (FPK #3) - single dose (45 ml) oral sodium phosphate (NaP), four bisacodyl tablets (5 mg), and one bisacodyl enema (10 mg)
Number of subjects: 171
Study 15555005 — intervention group
Group type: COMPARATOR
Intervention: 4 L polyethylene glycol solution (PEG)
Number of subjects: 171
Study 11869753 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated, clinic-based treatment delivery system emphasizing algorithm-driven somatotherapy, standardized patient education, and easy access to a primary mental health care provider.
Number of subjects: 191
Study 11869753 — intervention group
Group type: COMPARATOR
Intervention: Usual VA care
Number of subjects: 191
Study 9590631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod liver oil (CLO)
Number of subjects: 266
Study 9590631 — intervention group
Group type: EXPERIMENTAL
Intervention: Seal oil/CLO
Number of subjects: 266
Study 9590631 — intervention group
Group type: EXPERIMENTAL
Intervention: Whale oil (refined or unrefined)
Number of subjects: 266
Study 9590631 — intervention group
Group type: EXPERIMENTAL
Intervention: CLO/olive oil
Number of subjects: 266
Study 9590631 — intervention group
Group type: EXPERIMENTAL
Intervention: CLO/seal oil
Number of subjects: 266
Study 9590631 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil/CLO
Number of subjects: 266
Study 9590631 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 266
Study 7946230 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (one-month course including passive listening and active singing)
Number of subjects: 76
Study 7946230 — intervention group
Group type: COMPARATOR
Intervention: Standard medication (control group)
Number of subjects: 76
Study 3283830 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonionic contrast media (iohexol)
Number of subjects: 1000
Study 3283830 — intervention group
Group type: COMPARATOR
Intervention: Ionic contrast media (metrizoate)
Number of subjects: 1000
Study 29259050 — intervention group
Group type: EXPERIMENTAL
Intervention: LBEC0101
Number of subjects: 374
Study 29259050 — intervention group
Group type: COMPARATOR
Intervention: ETN-RP
Number of subjects: 374
Study 28786335 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic visual analogue scales (eVAS) for pain, fatigue, anxiety, and quality of life
Number of subjects: 104
Study 26246225 — intervention group
Group type: EXPERIMENTAL
Intervention: BFHI steps 1-9
Number of subjects: 975
Study 26246225 — intervention group
Group type: EXPERIMENTAL
Intervention: BFHI steps 1-10
Number of subjects: 975
Study 26246225 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 975
Study 23313462 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics
Number of subjects: 227
Study 23313462 — intervention group
Group type: COMPARATOR
Intervention: First-generation antipsychotics
Number of subjects: 227
Study 20839703 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable subcuticular staples
Number of subjects: 60
Study 20839703 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel staples
Number of subjects: 60
Study 18608832 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel pedals
Number of subjects: 22
Study 18608832 — intervention group
Group type: COMPARATOR
Intervention: Conventional pedals
Number of subjects: 22
Study 16398780 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofilament suture material (Biosyn)
Number of subjects: 1139
Study 16398780 — intervention group
Group type: COMPARATOR
Intervention: Multifilament suture (Dexon II)
Number of subjects: 1139
Study 14671147 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (30, 40, or 50 mg)
Number of subjects: 22
Study 14671147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 10994619 — intervention group
Group type: EXPERIMENTAL
Intervention: 250-kcal meal
Number of subjects: 10
Study 10994619 — intervention group
Group type: EXPERIMENTAL
Intervention: 550-kcal meal
Number of subjects: 10
Study 8788290 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic supplementation therapy
Number of subjects: 16
Study 8788290 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 16
Study 1289369 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) with topical polymyxin, amphotericin B, and tobramycin throughout ITU stay, and intravenous ceftazidime for the first 3 days only.
Number of subjects: 265
Study 1289369 — intervention group
Group type: COMPARATOR
Intervention: Contemporaneous control (CC)
Number of subjects: 265
Study 1289369 — intervention group
Group type: COMPARATOR
Intervention: Historical control (HC)
Number of subjects: 265
Study 1289369 — intervention group
Group type: EXPERIMENTAL
Intervention: SDD and CC groups
Number of subjects: 265
Study 4081704 — intervention group
Group type: EXPERIMENTAL
Intervention: HDCV vaccine
Number of subjects: 120
Study 4081704 — intervention group
Group type: COMPARATOR
Intervention: M‐M‐RR II vaccine
Number of subjects: 120
Study 30701555 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization tests
Number of subjects: 0
Study 30701555 — intervention group
Group type: COMPARATOR
Intervention: Parametric statistics
Number of subjects: 0
Study 30376687 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hormone therapy with estrogen and progestin
Number of subjects: 27447
Study 30376687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27447
Study 30376687 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy alone
Number of subjects: 27447
Study 27220529 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with infrared laser to two forehead sites while seated (total 8 min, 1064 nm continuous wave, 250 mW/cm(2), 60 J/cm(2) per site of 13.6 cm(2))
Number of subjects: 60
Study 27220529 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (EX) of high‐intensity (total 20 min, with 10‐min treadmill running at 85‐90 % VO2max)
Number of subjects: 60
Study 27220529 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (LLLT + EX)
Number of subjects: 60
Study 27220529 — intervention group
Group type: COMPARATOR
Intervention: Sham control (CON)
Number of subjects: 60
Study 24580983 — intervention group
Group type: EXPERIMENTAL
Intervention: NAP SACC intervention (educational workshops and consultation visits)
Number of subjects: 552
Study 22762718 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 231
Study 22762718 — intervention group
Group type: COMPARATOR
Intervention: Other causes of death (HF, other cardiovascular causes, noncardiovascular causes)
Number of subjects: 231
Study 20236907 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide with halogen light irradiation
Number of subjects: 10
Study 20236907 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide with LED/diode laser irradiation
Number of subjects: 10
Study 20236907 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide without irradiation
Number of subjects: 10
Study 20236907 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 10
Study 17430315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hemodiafiltration (HDF)
Number of subjects: 16
Study 17430315 — intervention group
Group type: COMPARATOR
Intervention: Forced alkaline diuresis
Number of subjects: 16
Study 17430315 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HDF and forced alkaline diuresis
Number of subjects: 16
Study 15959371 — intervention group
Group type: EXPERIMENTAL
Intervention: Single percutaneous electrodes
Number of subjects: 20
Study 15959371 — intervention group
Group type: COMPARATOR
Intervention: Dual 7-mm percutaneous electrodes
Number of subjects: 20
Study 15959371 — intervention group
Group type: COMPARATOR
Intervention: Dual 10-mm percutaneous electrodes
Number of subjects: 20
Study 15959371 — intervention group
Group type: COMPARATOR
Intervention: Dual electrodes (both 7-mm and 10-mm)
Number of subjects: 20
Study 12239258 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 70
Study 12239258 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal dialysis
Number of subjects: 70
Study 10355234 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure semantic violation condition
Number of subjects: 0
Study 10355234 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined semantic and syntactic violation condition
Number of subjects: 0
Study 10355234 — intervention group
Group type: EXPERIMENTAL
Intervention: Phrase structure violation conditions
Number of subjects: 0
Study 10355234 — intervention group
Group type: EXPERIMENTAL
Intervention: Both semantic violation conditions
Number of subjects: 0
Study 8594267 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beta carotene, 50 mg per day for a median of 4.3 years
Number of subjects: 1720
Study 8594267 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial plasma beta carotene concentrations in the highest quartile (>0.52 micromol/L)
Number of subjects: 1720
Study 2020314 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (1.5, 3, and 6 micrograms/kg/day)
Number of subjects: 15
Study 2020314 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (3 and 6 micrograms/kg/day)
Number of subjects: 15
Study 2020314 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (6 micrograms/kg/day)
Number of subjects: 15
Study 2020314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2020314 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 15
Study 7044526 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 75
Study 7044526 — intervention group
Group type: COMPARATOR
Intervention: Aminoglutethimide-hydrocortisone
Number of subjects: 75
Study 30175628 — intervention group
Group type: EXPERIMENTAL
Intervention: Fab antivenom (FabAV)
Number of subjects: 45
Study 30175628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 29522571 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural sensorimotor training (SMT)
Number of subjects: 22
Study 29522571 — intervention group
Group type: COMPARATOR
Intervention: Sham exercise (sub-effective low-intensity training)
Number of subjects: 22
Study 26939875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR/IDC+ Gleason score ≥7 (n=189)
Number of subjects: 1031
Study 26939875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR/IDC- Gleason score ≥7 (n=356)
Number of subjects: 1031
Study 26939875 — intervention group
Group type: EXPERIMENTAL
Intervention: Gleason score 6 (n=486)
Number of subjects: 1031
Study 26939875 — intervention group
Group type: COMPARATOR
Intervention: CR/IDC- Gleason score 3+4=7
Number of subjects: 1031
Study 26939875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR/IDC+ Gleason score 3+4=7
Number of subjects: 1031
Study 26939875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR/IDC+ status
Number of subjects: 1031